Drug intelligence / Profile preview

Xinju Xiaogao Prescription

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Xinju Xiaogao Prescription is a traditional Chinese medicine (TCM) herbal formulation studied for its effects on overweight and adiposity, particularly in the context of "stagnation of Qi causing phlegm retention" according to TCM theory. It is not a single pharmaceutical compound but rather a multi-ingredient herbal preparation. The precise composition and mechanism of action are not detailed in Western pharmacological terms, but it is used within TCM practice to address metabolic imbalances associated with overweight conditions[1][2]. There is no evidence that it has been developed or approved as a pharmaceutical drug by regulatory agencies such as the FDA.

Brand names: Xinju Xiaogao Prescription
Other names: Xinju Xiaogao prescription

Beyond the preview

Go deeper on Xinju Xiaogao Prescription.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinju Xiaogao Prescription.

Explore the full profile